PortfoliosLab logoPortfoliosLab logo
CYTK vs. BLD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CYTK vs. BLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cytokinetics, Incorporated (CYTK) and TopBuild Corp. (BLD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


CYTK

1D
-4.09%
1M
-10.82%
6M
22.06%
YTD
21.39%
1Y
110.22%
3Y*
33.39%
5Y*
21.05%
10Y*
20.76%
ALL TIME*
-0.69%

BLD

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$131.51M$142.86M$201.13M

CYTK vs. BLD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CYTK
Cytokinetics, Incorporated
21.39%35.08%-43.66%82.21%0.53%119.35%95.85%67.88%-22.45%-32.92%
BLD
TopBuild Corp.
-15.02%34.00%-16.81%139.16%-43.28%49.89%78.58%129.07%-40.59%112.75%

Correlation

The correlation between CYTK and BLD is 0.19, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.19

Correlation (3Y)
Balances recent behavior with more history.

0.25

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.28

Correlation (10Y)
Provides a long-term view across more market conditions.

0.26

Correlation (All Time)
Calculated using the full available price history since Jul 1, 2015

0.25

Fundamentals

Market Cap

CYTK:

$9.60B

BLD:

$9.97B

EPS

CYTK:

-$6.81

BLD:

$17.87

PS Ratio

CYTK:

88.85

BLD:

1.78

Total Revenue (TTM)

CYTK:

$105.82M

BLD:

$5.62B

Gross Profit (TTM)

CYTK:

$95.60M

BLD:

$1.62B

EBITDA (TTM)

CYTK:

-$748.97M

BLD:

$933.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CYTK vs. BLD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CYTK
CYTK Risk / Return Rank: 9393
Overall Rank
CYTK Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CYTK Sortino Ratio Rank: 9393
Sortino Ratio Rank
CYTK Omega Ratio Rank: 9090
Omega Ratio Rank
CYTK Calmar Ratio Rank: 9898
Calmar Ratio Rank
CYTK Martin Ratio Rank: 9696
Martin Ratio Rank

BLD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CYTK vs. BLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and TopBuild Corp. (BLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CYTKBLDDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.36

Calmar ratioReturn relative to maximum drawdown

7.03

Martin ratioReturn relative to average drawdown

15.41

CYTK vs. BLD - Sharpe Ratio Comparison


Loading charts...

Drawdowns

CYTK vs. BLD - Drawdown Comparison


Loading charts...

Drawdown Indicators


CYTKBLDDifference

Max Drawdown

Largest peak-to-trough decline

-97.09%

Max Drawdown (1Y)

Largest decline over 1 year

-15.01%

Max Drawdown (3Y)

Largest decline over 3 years

-72.39%

Max Drawdown (5Y)

Largest decline over 5 years

-72.39%

Max Drawdown (10Y)

Largest decline over 10 years

-72.39%

Current Drawdown

Current decline from peak

-28.62%

Average Drawdown

Average peak-to-trough decline

-75.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.89%

Volatility

CYTK vs. BLD - Volatility Comparison


Loading charts...

Volatility by Period


CYTKBLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.03%

Volatility (6M)

Calculated over the trailing 6-month period

32.41%

Volatility (1Y)

Calculated over the trailing 1-year period

60.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.91%

Dividends

CYTK vs. BLD - Dividend Comparison

Neither CYTK nor BLD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CYTK vs. BLD - Financials Comparison

This section allows you to compare key financial metrics between Cytokinetics, Incorporated and TopBuild Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


CYTK and BLD have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CYTK and BLD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer